{"gene":"IL19","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2001,"finding":"IL-19 binds exclusively to the type I IL-20R complex (IL-20Rα/IL-20Rβ), not the type II complex (IL-22R/IL-20Rβ), and binding results in STAT3 phosphorylation and activation of STAT-responsive promoters.","method":"Receptor binding assays, STAT phosphorylation assays, reporter gene (minimal STAT-binding promoter) in cell lines","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — direct receptor binding and STAT3 phosphorylation demonstrated; replicated across two receptor complexes with clear specificity","pmids":["11564763"],"is_preprint":false},{"year":2000,"finding":"IL-19 mRNA is induced in monocytes by LPS stimulation (delayed relative to IL-10, detectable at 4 h); IL-19 does not signal through the canonical IL-10 receptor complex, implying a distinct receptor.","method":"Northern blot / RT-PCR time-course in LPS-stimulated monocytes; receptor binding exclusion experiments","journal":"Genes and immunity","confidence":"Medium","confidence_rationale":"Tier 2 — clean KD/expression with defined cellular readout; single lab but multiple conditions","pmids":["11196675"],"is_preprint":false},{"year":2002,"finding":"IL-19 treatment of monocytes induces production of IL-6 and TNF-α, promotes monocyte apoptosis, and increases reactive oxygen species production; IL-19 promoter region (394 bp upstream of exon 1) drives transcription.","method":"ELISA for cytokine production, apoptosis assays, luciferase reporter assay with promoter deletion constructs","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (ELISA, apoptosis, ROS, reporter); single lab","pmids":["12370360"],"is_preprint":false},{"year":2004,"finding":"IL-19 induces Th2 cytokine production (IL-4, IL-5, IL-10, IL-13) in activated T cells; induction of IL-13 requires prior T cell activation.","method":"In vitro cytokine stimulation of T cells, ELISA for cytokine production; in vivo gene electroporation in mice","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo data with defined cytokine readouts; single lab","pmids":["15557163"],"is_preprint":false},{"year":2005,"finding":"IL-19 stimulates its own expression (auto-induction) and induces IL-10 production in PBMCs; IL-10 in turn potently down-regulates IL-19 auto-induction; IL-19 acts as a transcriptional activator of IL-10 (increased IL-10 mRNA); IL-19 skews dendritic cell maturation toward increased IL-10 without affecting IL-12.","method":"Quantitative RT-PCR, ELISA on PBMC supernatants, dendritic cell differentiation assays","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (RT-PCR, ELISA, DC assay); single lab","pmids":["15827959"],"is_preprint":false},{"year":2006,"finding":"IL-19 (along with IL-20 and IL-24) does not activate STAT molecules in immune cells (consistent with absence of cognate receptor chains IL-20R1/IL-20R2 on immune cells); instead, acts on skin keratinocytes and other epithelial tissues expressing both receptor complexes.","method":"STAT phosphorylation assays in immune and epithelial cells; RT-PCR and flow cytometry for receptor expression","journal":"Experimental dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic receptor expression and signaling analysis across cell types; single lab but multiple methods","pmids":["17083366"],"is_preprint":false},{"year":2006,"finding":"A2B adenosine receptor activation on bronchial epithelial cells induces IL-19 release; released IL-19 activates monocytes to produce TNF-α, which in turn upregulates A2B receptor expression, forming a positive inflammatory feedback loop.","method":"NECA treatment + selective A2B antagonist CVT-6694 in HBEC cultures; ELISA for IL-19 and TNF-α; THP-1 monocyte activation assays","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological receptor blockade plus functional cytokine readouts; single lab","pmids":["16778150"],"is_preprint":false},{"year":2008,"finding":"IL-19 induces STAT3 activation and increases IL-6 production in rheumatoid arthritis synovial cells (RASC); IL-19 reduces RASC apoptosis induced by serum starvation, suggesting an anti-apoptotic autocrine role in synovial hyperplasia.","method":"Western blot for STAT3 phosphorylation, ELISA for IL-6, Hoechst staining, annexin V flow cytometry, caspase-3 activity assay","journal":"Rheumatology (Oxford)","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal apoptosis and signaling assays; single lab","pmids":["18397956"],"is_preprint":false},{"year":2008,"finding":"IL-17A and IL-4/IL-13 synergistically upregulate IL-19 expression in airway epithelial cells; IL-19 transcription is regulated by NF-κB, and the IL-13+IL-17A combination shifts this to STAT6-dependent regulation; STAT6-binding elements were confirmed in the IL-19 promoter by chromatin immunoprecipitation.","method":"siRNA knockdown, chemical inhibitors, chromatin immunoprecipitation (ChIP), luciferase reporter assays, well-differentiated primary bronchial epithelial cultures","journal":"Journal of allergy and clinical immunology","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP + siRNA + inhibitor approaches provide strong mechanistic evidence for transcriptional regulation","pmids":["18539194"],"is_preprint":false},{"year":2010,"finding":"IL-19 reduces abundance and stability of proliferative/inflammatory mRNAs (Cyclin D1, IL-1β, IL-8, COX2) in vascular smooth muscle cells (VSMC) by decreasing cytoplasmic abundance and serine phosphorylation of the mRNA stability factor HuR, and by reducing PKCα activation; actinomycin D chase confirms reduced mRNA half-life; HuR siRNA knockdown phenocopies IL-19.","method":"Actinomycin D transcription block mRNA decay assays, immunoblot for HuR and PKCα, HuR siRNA knockdown, quantitative RT-PCR","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (mRNA decay, siRNA, kinase phosphorylation) in primary human VSMCs; single lab but rigorous","pmids":["20451530"],"is_preprint":false},{"year":2011,"finding":"IL-19 induces HO-1 mRNA and protein expression in human VSMC (not endothelial cells) via STAT3 activation; STAT3 siRNA and mutation of the STAT-binding site in the HO-1 promoter significantly reduce IL-19-induced HO-1; IL-19-driven HO-1 mediates reduction of ROS concentrations; IL-19 reduces vascular ROS in vivo in TNFα-treated mice.","method":"Quantitative RT-PCR, immunoblot, ELISA, STAT3 siRNA, HO-1 promoter mutagenesis, annexin V flow cytometry, in vivo ROS measurement","journal":"Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — promoter mutagenesis + siRNA + in vitro and in vivo ROS assays; multiple orthogonal methods","pmids":["22158875"],"is_preprint":false},{"year":2013,"finding":"IL-19 promotes cutaneous wound healing in vivo; in vitro, IL-19 upregulates KGF (keratinocyte growth factor) expression in fibroblasts, and conditioned medium from IL-19-treated fibroblasts promotes keratinocyte proliferation; IL-19 directly increases keratinocyte migration.","method":"Full-thickness mouse wound model with topical IL-19; BrdU proliferation assay, transwell migration assay, RT-PCR, conditioned medium transfer","journal":"Cytokine","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo and in vitro functional assays with defined cellular mechanisms; single lab","pmids":["23582717"],"is_preprint":false},{"year":2014,"finding":"IL-19 knockout mice develop more severe neointimal hyperplasia after carotid artery ligation; IL-19 KO VSMCs proliferate and migrate faster, with greater inflammatory cytokine expression and monocyte adhesion; all phenotypes are rescued by exogenous recombinant IL-19.","method":"IL-19 knockout mouse carotid ligation model, neointima/intima ratio morphometry, VSMC proliferation/migration assays, recombinant IL-19 rescue injection","journal":"American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse model with rescue by exogenous protein, multiple in vitro and in vivo phenotypic readouts; replicated across multiple assays","pmids":["24814101"],"is_preprint":false},{"year":2014,"finding":"IL-19 production is induced in keratinocytes by IL-17A and amplified by TNF-α and IL-22; IL-19 amplifies IL-17A effects on keratinocytes including induction of β-defensins, IL-19 itself, IL-23p19, and Th17/neutrophil-attracting chemokines; IL-19 is a component of the IL-23/IL-17 pathogenic axis in psoriasis.","method":"Primary keratinocyte stimulation, quantitative cytokine measurement, gene expression analysis","journal":"Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — systematic functional studies in primary keratinocytes with defined cytokine stimuli and readouts; single lab","pmids":["25046339"],"is_preprint":false},{"year":2016,"finding":"Exogenous IL-19 halts progression of preformed atherosclerotic plaque in LDLR−/− mice; IL-19 promotes M2 macrophage polarization via activation of STAT3, STAT6, KLF4, and PPARγ; IL-19 regulates macrophage cholesterol homeostasis through PPARγ-dependent scavenger receptor-mediated cholesterol uptake and ABCA1-mediated cholesterol efflux.","method":"LDLR−/− mouse atherosclerosis model with rIL-19 injection, plaque morphometry, immunostaining, western blot for STAT3/STAT6/KLF4/PPARγ pathway components, cholesterol uptake and efflux assays","journal":"American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse model with mechanistic pathway validation using multiple signaling and lipid metabolism assays; rigorous","pmids":["26952642"],"is_preprint":false},{"year":2017,"finding":"IL-19 induces expression of miR133a in VSMC; miR133a targets and reduces mRNA abundance, stability, and protein expression of LDLRAP1 (LDL receptor adaptor protein 1), thereby reducing oxLDL uptake and lipid accumulation in VSMCs.","method":"miRNA quantification, miR133a transfection, LDLRAP1 siRNA, mRNA stability assays, oxLDL uptake assays in primary human VSMCs; miR133a plasma measurement in hyperlipidemic patients","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA and miRNA overexpression with mRNA stability and functional lipid uptake assays; single lab","pmids":["28257760"],"is_preprint":false},{"year":2018,"finding":"IL-19 genetic deletion (Il19−/− × Ldlr−/− double KO) exacerbates atherosclerosis; dKO mice show increased HuR (mRNA stability protein) abundance in spleen and aortic arch; IL-19 induces miR133a which targets and reduces HuR; loss of IL-19 increases inflammatory cytokine mRNA stability via elevated HuR.","method":"Double KO mouse model, bone marrow transplantation, qRT-PCR, western blot, mRNA stability assays in isolated BMDM and VSMCs, miR133a quantification","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO model with bone marrow transplantation to define cellular source, multiple orthogonal molecular assays; strong evidence","pmids":["29674474"],"is_preprint":false},{"year":2018,"finding":"FXR1 (fragile-X-related protein) is identified as an IL-19-responsive, HuR-interacting protein in VSMCs; FXR1-HuR interaction is RNA-tethered (abrogated by RNase); FXR1 destabilizes pro-inflammatory mRNAs (including TNFα, which it binds via ARE and 3' UTR elements); IL-19 increases FXR1 expression and FXR1 is required for IL-19-mediated reduction of HuR.","method":"LC-MS/MS proteomics, RNA EMSA, RNA immunoprecipitation (RIP), siRNA knockdown, FXR1 overexpression, mRNA stability assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 — proteomics identification with RNA EMSA, RIP, siRNA rescue, and mRNA stability; multiple orthogonal methods in single rigorous study","pmids":["30067974"],"is_preprint":false},{"year":2019,"finding":"IL-20R1 deficiency abolishes IL-19-induced Th2 cell differentiation in vitro; in vivo, IL-20R1 deficiency reduces allergen-induced airway hyperresponsiveness, Th2 cytokine expression, and immune cell infiltration; anti-IL-20R1 mAb and anti-IL-19 antibodies both ameliorate allergic lung inflammation.","method":"IL-20R1 KO mouse model, anti-IL-20R1 mAb treatment, anti-IL-19 pAb, in vitro Th2 differentiation assay, airway hyperresponsiveness measurement, BAL cell counting","journal":"Frontiers in immunology","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with pharmacological rescue, multiple in vivo and in vitro readouts; mechanistically defines IL-20R1 as the required signaling receptor for IL-19-driven Th2 responses","pmids":["31114590"],"is_preprint":false},{"year":2019,"finding":"IL-19 up-regulates MUC5AC mucin production in primary human nasal epithelial cells via STAT3 pathway; IL-20R2 siRNA knockdown and STAT3 inhibitor (cryptotanshinone) attenuate IL-19-induced MUC5AC.","method":"Recombinant IL-19 stimulation of primary nasal epithelial cells, siRNA knockdown of IL-20R2, STAT3 inhibitor, RT-qPCR, ELISA, western blot, confocal microscopy","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA and pharmacological inhibitor approaches with multiple readouts; single lab","pmids":["31379870"],"is_preprint":false},{"year":2021,"finding":"IL-19 is produced predominantly by osteocytes and stimulates granulopoiesis by activating IL-20Rβ/STAT3 signaling in neutrophil progenitors; mTORC1 activation in osteocytes increases IL-19 production and promyelocyte expansion; neutralizing endogenous IL-19 or depleting its receptor inhibits neutrophil development; low-dose IL-19 reverses chemotherapy/irradiation-induced neutropenia.","method":"Dmp1-Cre mTORC1 activation mouse model, IL-19 neutralizing antibody, IL-20Rβ depletion, bone marrow analysis, STAT3 activation assays, neutropenia rescue experiments","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — genetic mouse models, receptor depletion, neutralization, and in vivo rescue; multiple orthogonal approaches establishing pathway position","pmids":["33684929"],"is_preprint":false},{"year":2021,"finding":"DNA damage induces IL-19 expression through JNK and cGAS-STING pathways; IL-19 expression is required for subsequent DNA damage-induced production of IL-1, IL-6, and IL-8; IL-19 induction by ionizing radiation depends on reactive oxygen species and ASK1-JNK, while ATR inhibition-induced IL-19 requires cGAS-STING; IL-19-independent cGAS-STING signaling drives PDL1 expression.","method":"Pathway inhibitors (JNK, ROS, cGAS-STING), siRNA suppression of IL19, ATR inhibitor treatment, ionizing radiation, cytokine ELISA, gene expression analysis","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown of IL19 combined with multiple genetic/pharmacological pathway interrogations; epistasis established between DNA damage pathways and IL-19-dependent cytokine cascade","pmids":["34932373"],"is_preprint":false},{"year":2021,"finding":"IL-17A induces IL-19 and IL-24 expression directly in skin fibroblasts and keratinocytes; intrinsic higher IL-19 expression in psoriatic versus healthy skin fibroblasts; IL-17A neutralization in T cell-fibroblast co-culture suppresses IL-19 and IL-24; IL-19 (with IL-24) contributes to keratinocyte proliferation.","method":"Human skin fibroblast-T cell co-culture, anti-IL-17A neutralization, imiquimod mouse psoriasis model with anti-IL-10 antibody, histology, flow cytometry","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 — neutralization in co-culture plus in vivo mouse model; single lab","pmids":["34616394"],"is_preprint":false},{"year":2021,"finding":"IL-19 KO mice on CDAHFD develop worse NASH (more liver injury, inflammation, fibrosis, elevated IL-6/TNF-α/TGF-β); in vitro, IL-19 decreases palmitate-induced triglyceride and cholesterol accumulation in hepatocytes, reduces fatty acid synthesis gene expression, and increases ATP content, indicating IL-19 suppresses lipid metabolism in hepatocytes.","method":"IL-19 KO mouse CDAHFD model, histopathology, qRT-PCR, ELISA, in vitro HepG2 lipid accumulation assays","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse phenotype with in vitro mechanistic follow-up; single lab","pmids":["34944021"],"is_preprint":false},{"year":2025,"finding":"IL-19 promotes lymphangiogenesis (human dermal lymphatic endothelial cell migration, network formation, proliferation); IL-19 induces rapid VE-cadherin phosphorylation and increases lymphatic endothelial monolayer permeability; Il19/Ldlr double KO mice on high-fat diet show impaired lymphatic drainage, fewer lymphatic branch points, and increased zipper junctions.","method":"Human dermal lymphatic endothelial cell culture assays, immunocytochemistry, electric cell-substrate impedance sensing, RNA sequencing, in vivo lymphatic drainage in double KO mice","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional assays with in vivo genetic model validation; single lab","pmids":["40371466"],"is_preprint":false},{"year":2019,"finding":"IL-19 induces MMP-9 production in human nasal epithelial cells through ERK and NF-κB signaling pathways; ERK and NF-κB inhibitors attenuate IL-19-induced MMP-9; siRNA knockdown of IL-20R1 suppresses ERK/NF-κB activation and MMP-9 expression; IL-13 and IL-17A stimulate IL-19 production in nasal epithelial cells.","method":"siRNA knockdown of IL-20R1, ERK and NF-κB inhibitors, western blot, RT-qPCR, ELISA, immunofluorescence in primary human nasal epithelial cells","journal":"Clinical and translational allergy","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA and pharmacological inhibition with multiple readouts; single lab","pmids":["33900049"],"is_preprint":false}],"current_model":"IL-19 is an IL-10 family cytokine that signals exclusively through the type I IL-20R complex (IL-20Rα/IL-20Rβ) to activate STAT3, driving diverse context-dependent anti- or pro-inflammatory effects: in vascular smooth muscle cells it suppresses inflammatory mRNA stability by reducing HuR via miR133a induction and increasing the counter-regulatory RNA-binding protein FXR1; in immune and epithelial cells it promotes Th2 polarization and keratinocyte responses; it is induced by DNA damage via JNK and cGAS-STING pathways and is required upstream of IL-1/IL-6/IL-8 production; and in osteocytes it drives neutrophil progenitor expansion through IL-20Rβ/STAT3 signaling."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that IL-19 is an inducible monocyte cytokine distinct from IL-10 answered whether IL-19 uses the IL-10 receptor, demonstrating it signals through an independent pathway.","evidence":"Northern blot/RT-PCR time-course in LPS-stimulated monocytes with receptor binding exclusion","pmids":["11196675"],"confidence":"Medium","gaps":["Cognate receptor not yet identified","Downstream signaling pathway unknown","Single-lab observation"]},{"year":2001,"claim":"Identification of IL-20Rα/IL-20Rβ as the exclusive receptor complex and STAT3 as the principal effector resolved how IL-19 transduces signal, establishing its mechanistic distinction from other IL-10 family members.","evidence":"Receptor binding assays and STAT3 phosphorylation/reporter assays across both IL-20R complexes","pmids":["11564763"],"confidence":"High","gaps":["Downstream transcriptional targets of STAT3 in this context undefined","Cell-type specificity of receptor expression not systematically mapped"]},{"year":2002,"claim":"Demonstrating that IL-19 induces IL-6, TNFα, apoptosis, and ROS in monocytes established it as a pro-inflammatory stimulus in myeloid cells, posing the question of how this reconciles with its IL-10-family membership.","evidence":"ELISA, apoptosis assays, ROS measurement, and promoter-reporter analysis in monocytes","pmids":["12370360"],"confidence":"Medium","gaps":["Receptor expression on monocytes not directly confirmed","Whether effects are direct or paracrine not resolved"]},{"year":2004,"claim":"Showing IL-19 drives Th2 cytokine production (IL-4, IL-5, IL-10, IL-13) in T cells established its role as a Th2-polarizing cytokine, later confirmed genetically.","evidence":"In vitro T cell cytokine stimulation and in vivo gene electroporation in mice","pmids":["15557163"],"confidence":"Medium","gaps":["Whether IL-19 acts directly on T cells or through APCs not resolved","Receptor expression on T cells not confirmed"]},{"year":2005,"claim":"Discovery of IL-19 auto-induction and reciprocal IL-10 feedback defined a self-amplifying circuit with a built-in brake, explaining how IL-19 responses are calibrated.","evidence":"qRT-PCR and ELISA in PBMCs; dendritic cell maturation assays","pmids":["15827959"],"confidence":"Medium","gaps":["Molecular mechanism of auto-induction not defined","In vivo relevance of feedback loop not tested"]},{"year":2006,"claim":"Systematic analysis showing IL-19 activates STAT in epithelial/keratinocyte cells but not immune cells clarified cell-type-restricted signaling, and the A2B adenosine receptor–IL-19–TNFα loop placed IL-19 in airway inflammatory amplification circuits.","evidence":"STAT phosphorylation across cell types; A2B receptor pharmacological blockade with cytokine ELISA","pmids":["17083366","16778150"],"confidence":"Medium","gaps":["Apparent contradiction with monocyte activation data from 2002 not reconciled","Whether receptor expression is regulated dynamically under inflammation not addressed"]},{"year":2008,"claim":"Two advances established transcriptional regulation of IL-19 (NF-κB and STAT6 via IL-17A/IL-13 in airway epithelia) and its autocrine role in synovial cells (STAT3 → IL-6, anti-apoptosis), connecting IL-19 to both upstream inducers and downstream effector pathways in disease-relevant tissues.","evidence":"ChIP, siRNA, inhibitor, and promoter mutagenesis in bronchial epithelial cells; STAT3/apoptosis assays in rheumatoid synovial cells","pmids":["18539194","18397956"],"confidence":"High","gaps":["Whether STAT6 regulation applies beyond airway epithelium unknown","In vivo evidence for synovial autocrine loop lacking"]},{"year":2010,"claim":"Identification of HuR destabilization as the mechanism by which IL-19 reduces inflammatory mRNA half-life in VSMCs established a post-transcriptional anti-inflammatory mechanism distinct from transcriptional repression.","evidence":"Actinomycin D mRNA decay assays, HuR immunoblot, PKCα analysis, HuR siRNA phenocopy in primary human VSMCs","pmids":["20451530"],"confidence":"High","gaps":["Upstream signal from IL-20R/STAT3 to PKCα/HuR not delineated","Whether mechanism operates in non-vascular cell types unknown"]},{"year":2011,"claim":"Showing IL-19 induces HO-1 via STAT3 to reduce ROS in VSMCs and in vivo established a cytoprotective effector arm, broadening IL-19's anti-inflammatory repertoire beyond mRNA destabilization.","evidence":"STAT3 siRNA, HO-1 promoter mutagenesis, in vivo ROS measurement in TNFα-treated mice","pmids":["22158875"],"confidence":"High","gaps":["Relative contribution of HO-1 versus HuR pathway not assessed","Whether HO-1 induction occurs in macrophages unclear"]},{"year":2014,"claim":"IL-19 KO mice developing worse neointimal hyperplasia provided genetic loss-of-function evidence that endogenous IL-19 is a vascular-protective factor, while keratinocyte studies placed IL-19 within the IL-23/IL-17 psoriatic axis as an amplifier.","evidence":"IL-19 KO carotid ligation model with rescue; primary keratinocyte cytokine stimulation","pmids":["24814101","25046339"],"confidence":"High","gaps":["Cell-type-specific conditional KO not performed","Whether vascular protection is VSMC-autonomous or involves macrophage M2 polarization unclear"]},{"year":2016,"claim":"Demonstration that exogenous IL-19 halts atherosclerotic plaque progression via M2 macrophage polarization (STAT3/STAT6/KLF4/PPARγ) and cholesterol efflux established a multi-pronged atheroprotective mechanism acting on both inflammation and lipid handling.","evidence":"LDLR−/− mouse atherosclerosis model with rIL-19 injection; cholesterol uptake/efflux assays; signaling pathway western blots","pmids":["26952642"],"confidence":"High","gaps":["Whether endogenous IL-19 levels are sufficient for this effect not tested at this point","STAT6 activation had not been previously reported for IL-19 — mechanism of STAT6 engagement not defined"]},{"year":2017,"claim":"Identification of miR133a as the mediator by which IL-19 reduces HuR and LDLRAP1 connected IL-19 signaling to a specific microRNA effector and explained how IL-19 limits oxLDL uptake in VSMCs.","evidence":"miR133a quantification, transfection, LDLRAP1 siRNA, mRNA stability and oxLDL uptake assays in primary human VSMCs","pmids":["28257760"],"confidence":"Medium","gaps":["Transcriptional mechanism by which IL-19/STAT3 induces miR133a not defined","Single-lab finding without independent replication"]},{"year":2018,"claim":"Double-KO (Il19/Ldlr) mice confirmed IL-19 genetically restrains atherosclerosis through miR133a-HuR-dependent inflammatory mRNA destabilization, while parallel work identified FXR1 as a novel IL-19-induced RNA-binding protein that antagonizes HuR and is required for IL-19's post-transcriptional anti-inflammatory activity.","evidence":"Double KO mouse with bone marrow transplantation, miR133a and HuR quantification; LC-MS/MS proteomics, RNA EMSA, RIP, siRNA in VSMCs","pmids":["29674474","30067974"],"confidence":"High","gaps":["Whether FXR1 functions downstream of miR133a or in parallel not determined","FXR1-HuR interaction characterized only in VSMCs"]},{"year":2019,"claim":"Genetic and antibody-mediated disruption of IL-20R1 abolished IL-19-driven Th2 differentiation and allergic airway inflammation in vivo, definitively establishing the receptor requirement for IL-19's immune-polarizing function; concurrent studies showed IL-19 also engages ERK/NF-κB through IL-20R1 to induce MMP-9 in nasal epithelia.","evidence":"IL-20R1 KO mice, anti-IL-20R1 mAb, anti-IL-19 pAb in allergic airway model; siRNA and pharmacological inhibition in nasal epithelial cells","pmids":["31114590","33900049","31379870"],"confidence":"High","gaps":["How STAT3 versus ERK/NF-κB pathway selection occurs in different cell types undefined","Whether IL-20R1 blockade is therapeutic in human asthma not tested"]},{"year":2021,"claim":"Three distinct advances established IL-19 as: (1) the critical osteocyte-derived cytokine driving granulopoiesis via IL-20Rβ/STAT3 in neutrophil progenitors, rescuing chemotherapy-induced neutropenia; (2) a required intermediary in DNA damage-induced cytokine cascades through JNK and cGAS-STING; and (3) a hepatoprotective factor suppressing NASH-associated lipid accumulation.","evidence":"Dmp1-Cre mTORC1 mouse model with IL-19 neutralization and neutropenia rescue; siRNA/inhibitor epistasis after irradiation and ATR inhibition; IL-19 KO NASH model with in vitro hepatocyte lipid assays","pmids":["33684929","34932373","34944021"],"confidence":"High","gaps":["Whether osteocyte-derived IL-19 contributes to steady-state versus emergency granulopoiesis not fully resolved","cGAS-STING-to-IL-19 transcriptional mechanism not defined","NASH findings from single lab, not replicated"]},{"year":2025,"claim":"Discovery that IL-19 promotes lymphangiogenesis and regulates lymphatic endothelial permeability via VE-cadherin phosphorylation expanded its vascular biology to the lymphatic system, with Il19/Ldlr double KO mice showing impaired lymphatic drainage.","evidence":"Lymphatic endothelial cell migration/network/proliferation assays, impedance sensing, RNA-seq, in vivo lymphatic drainage in double KO mice","pmids":["40371466"],"confidence":"Medium","gaps":["Receptor and STAT pathway mediating lymphatic effects not defined","Single-lab finding","Whether lymphatic phenotype contributes to atherosclerosis severity not tested"]},{"year":null,"claim":"Key unresolved questions include: the structural basis and selectivity determinants of IL-19 binding to IL-20Rα/IL-20Rβ; the mechanism by which STAT3 activation leads to miR133a induction; how cell-type-specific pathway selection (STAT3 vs. STAT6 vs. ERK/NF-κB) is determined; and whether the post-transcriptional FXR1/HuR axis operates beyond vascular smooth muscle cells.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal structure of IL-19–receptor complex","miR133a transcriptional regulation by STAT3 not demonstrated directly","FXR1 pathway not tested in macrophages, keratinocytes, or neutrophil progenitors"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,17,14]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,2,3,20]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,7,10,14,18,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,4,13,18]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[9,15,16,17]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[8,21]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[14,23]}],"complexes":[],"partners":["IL20RA","IL20RB","STAT3","HUR","FXR1","PPARG","KLF4"],"other_free_text":[]},"mechanistic_narrative":"IL-19 is an IL-10 family cytokine that orchestrates context-dependent inflammatory, vascular, and tissue-repair responses by signaling through the IL-20Rα/IL-20Rβ (type I IL-20R) complex to activate STAT3, and in specific contexts STAT6, ERK, and NF-κB [PMID:11564763, PMID:22158875, PMID:31379870, PMID:33900049]. In vascular smooth muscle cells, IL-19 suppresses inflammatory mRNA stability by inducing miR133a, which reduces the mRNA-stabilizing factor HuR, and by upregulating the counter-regulatory RNA-binding protein FXR1, collectively destabilizing transcripts encoding cyclin D1, IL-1β, IL-8, and TNFα [PMID:20451530, PMID:30067974, PMID:29674474]. In immune cells, IL-19 promotes Th2 polarization and IL-10 induction through IL-20R1-dependent signaling, drives M2 macrophage polarization via STAT3/KLF4/PPARγ to limit atherosclerosis, and stimulates granulopoiesis through IL-20Rβ/STAT3 in neutrophil progenitors, while in epithelial and endothelial cells it induces mucin (MUC5AC), MMP-9, keratinocyte proliferation, and lymphangiogenesis [PMID:31114590, PMID:26952642, PMID:33684929, PMID:31379870, PMID:40371466]. IL-19 expression is transcriptionally regulated by NF-κB and STAT6 in response to IL-17A, IL-13, and LPS, and is induced by DNA damage through JNK and cGAS-STING pathways, positioning it as a required upstream mediator of damage-induced IL-1/IL-6/IL-8 production [PMID:18539194, PMID:34932373]."},"prefetch_data":{"uniprot":{"accession":"Q9UHD0","full_name":"Interleukin-19","aliases":["Melanoma differentiation-associated protein-like protein","NG.1"],"length_aa":177,"mass_kda":20.5,"function":"Cytokine that functions as an anti-inflammatory and proangiogenic factor (PubMed:34932373). Polarizes adaptive immunity to an anti-inflammatory phenotype through induction of T-helper 2 responses by both down-regulation of IFN-gamma and up-regulation of IL4 and IL13 (PubMed:16365913). Produced by osteocytes, stimulates granulopoiesis and neutrophil formation (By similarity). Exerts its biological effect through a receptor complex consisting of a heterodimer of IL20RA and IL20RB (PubMed:12351624). In turn, activates the Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathway, and importantly, STAT3 (PubMed:11564763)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9UHD0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IL19","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/IL19","total_profiled":1310},"omim":[{"mim_id":"605687","title":"INTERLEUKIN 19; IL19","url":"https://www.omim.org/entry/605687"},{"mim_id":"605619","title":"INTERLEUKIN 20; IL20","url":"https://www.omim.org/entry/605619"},{"mim_id":"604136","title":"INTERLEUKIN 24; IL24","url":"https://www.omim.org/entry/604136"},{"mim_id":"222100","title":"TYPE 1 DIABETES MELLITUS; T1D","url":"https://www.omim.org/entry/222100"},{"mim_id":"177900","title":"PSORIASIS 1, SUSCEPTIBILITY TO; PSORS1","url":"https://www.omim.org/entry/177900"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"cervix","ntpm":18.7},{"tissue":"salivary gland","ntpm":6.5}],"url":"https://www.proteinatlas.org/search/IL19"},"hgnc":{"alias_symbol":["IL-19","MDA1","ZMDA1","IL-10C","NG.1"],"prev_symbol":[]},"alphafold":{"accession":"Q9UHD0","domains":[{"cath_id":"1.20.1250.10","chopping":"2-171","consensus_level":"high","plddt":88.4849,"start":2,"end":171}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHD0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHD0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UHD0-F1-predicted_aligned_error_v6.png","plddt_mean":87.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IL19","jax_strain_url":"https://www.jax.org/strain/search?query=IL19"},"sequence":{"accession":"Q9UHD0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UHD0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UHD0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UHD0"}},"corpus_meta":[{"pmid":"11564763","id":"PMC_11564763","title":"Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11564763","citation_count":339,"is_preprint":false},{"pmid":"18405958","id":"PMC_18405958","title":"The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29.","date":"2008","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18405958","citation_count":256,"is_preprint":false},{"pmid":"12370360","id":"PMC_12370360","title":"IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12370360","citation_count":247,"is_preprint":false},{"pmid":"11196675","id":"PMC_11196675","title":"Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10).","date":"2000","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11196675","citation_count":236,"is_preprint":false},{"pmid":"17083366","id":"PMC_17083366","title":"Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs.","date":"2006","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17083366","citation_count":204,"is_preprint":false},{"pmid":"15557163","id":"PMC_15557163","title":"IL-19 induced Th2 cytokines and was up-regulated in asthma patients.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15557163","citation_count":148,"is_preprint":false},{"pmid":"25046339","id":"PMC_25046339","title":"IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25046339","citation_count":141,"is_preprint":false},{"pmid":"16365913","id":"PMC_16365913","title":"Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16365913","citation_count":123,"is_preprint":false},{"pmid":"17465720","id":"PMC_17465720","title":"IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases.","date":"2007","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/17465720","citation_count":98,"is_preprint":false},{"pmid":"16778150","id":"PMC_16778150","title":"A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase.","date":"2006","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16778150","citation_count":91,"is_preprint":false},{"pmid":"18539194","id":"PMC_18539194","title":"Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma.","date":"2008","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18539194","citation_count":88,"is_preprint":false},{"pmid":"15827959","id":"PMC_15827959","title":"Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10.","date":"2005","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15827959","citation_count":76,"is_preprint":false},{"pmid":"12941475","id":"PMC_12941475","title":"IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26.","date":"2003","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/12941475","citation_count":72,"is_preprint":false},{"pmid":"24527982","id":"PMC_24527982","title":"Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.","date":"2014","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24527982","citation_count":67,"is_preprint":false},{"pmid":"18397956","id":"PMC_18397956","title":"Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.","date":"2008","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18397956","citation_count":67,"is_preprint":false},{"pmid":"20001767","id":"PMC_20001767","title":"Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints.","date":"2010","source":"Scandinavian journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/20001767","citation_count":62,"is_preprint":false},{"pmid":"22905186","id":"PMC_22905186","title":"Arabidopsis MDA1, a nuclear-encoded protein, functions in chloroplast development and abiotic stress responses.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22905186","citation_count":57,"is_preprint":false},{"pmid":"22186257","id":"PMC_22186257","title":"Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/22186257","citation_count":57,"is_preprint":false},{"pmid":"28557341","id":"PMC_28557341","title":"Over-expression of mutated ZmDA1 or ZmDAR1 gene improves maize kernel yield by enhancing starch synthesis.","date":"2017","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/28557341","citation_count":57,"is_preprint":false},{"pmid":"20451530","id":"PMC_20451530","title":"Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20451530","citation_count":53,"is_preprint":false},{"pmid":"15889129","id":"PMC_15889129","title":"Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis.","date":"2005","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15889129","citation_count":53,"is_preprint":false},{"pmid":"17263806","id":"PMC_17263806","title":"Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis.","date":"2007","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17263806","citation_count":51,"is_preprint":false},{"pmid":"21073280","id":"PMC_21073280","title":"IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/21073280","citation_count":50,"is_preprint":false},{"pmid":"22158875","id":"PMC_22158875","title":"Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22158875","citation_count":45,"is_preprint":false},{"pmid":"19159673","id":"PMC_19159673","title":"Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide.","date":"2009","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/19159673","citation_count":45,"is_preprint":false},{"pmid":"18246602","id":"PMC_18246602","title":"IL-19 is involved in the pathogenesis of endotoxic shock.","date":"2008","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/18246602","citation_count":42,"is_preprint":false},{"pmid":"29681905","id":"PMC_29681905","title":"IL-19 and Other IL-20 Family Member Cytokines in Vascular Inflammatory Diseases.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29681905","citation_count":41,"is_preprint":false},{"pmid":"18479293","id":"PMC_18479293","title":"Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.","date":"2008","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18479293","citation_count":41,"is_preprint":false},{"pmid":"34616394","id":"PMC_34616394","title":"Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34616394","citation_count":38,"is_preprint":false},{"pmid":"26952642","id":"PMC_26952642","title":"IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26952642","citation_count":38,"is_preprint":false},{"pmid":"22103848","id":"PMC_22103848","title":"IL-19 as a potential therapeutic in autoimmune and inflammatory diseases.","date":"2011","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/22103848","citation_count":37,"is_preprint":false},{"pmid":"23582717","id":"PMC_23582717","title":"Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression.","date":"2013","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/23582717","citation_count":35,"is_preprint":false},{"pmid":"24677051","id":"PMC_24677051","title":"Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member.","date":"2014","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/24677051","citation_count":35,"is_preprint":false},{"pmid":"29674474","id":"PMC_29674474","title":"Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Il19-/-×Ldlr-/- Double Knockout Mice by Dysregulation of mRNA Stability Protein HuR (Human Antigen R).","date":"2018","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29674474","citation_count":33,"is_preprint":false},{"pmid":"30067974","id":"PMC_30067974","title":"FXR1 Is an IL-19-Responsive RNA-Binding Protein that Destabilizes Pro-inflammatory Transcripts in Vascular Smooth Muscle Cells.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30067974","citation_count":33,"is_preprint":false},{"pmid":"22583192","id":"PMC_22583192","title":"Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.","date":"2012","source":"Allergy","url":"https://pubmed.ncbi.nlm.nih.gov/22583192","citation_count":32,"is_preprint":false},{"pmid":"17449492","id":"PMC_17449492","title":"Expression of IL-19 correlates with Th2 cytokines in uraemic patients.","date":"2007","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/17449492","citation_count":31,"is_preprint":false},{"pmid":"28257760","id":"PMC_28257760","title":"Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC.","date":"2017","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28257760","citation_count":31,"is_preprint":false},{"pmid":"24814101","id":"PMC_24814101","title":"IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.","date":"2014","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24814101","citation_count":30,"is_preprint":false},{"pmid":"28864472","id":"PMC_28864472","title":"The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28864472","citation_count":30,"is_preprint":false},{"pmid":"22458549","id":"PMC_22458549","title":"Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.","date":"2012","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/22458549","citation_count":30,"is_preprint":false},{"pmid":"33684929","id":"PMC_33684929","title":"Osteocytes regulate neutrophil development through IL-19: a potent cytokine for neutropenia treatment.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33684929","citation_count":28,"is_preprint":false},{"pmid":"17360593","id":"PMC_17360593","title":"WD40 protein Mda1 is purified with Dnm1 and forms a dividing ring for mitochondria before Dnm1 in Cyanidioschyzon merolae.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360593","citation_count":27,"is_preprint":false},{"pmid":"32343843","id":"PMC_32343843","title":"The Arabidopsis mTERF-repeat MDA1 protein plays a dual function in transcription and stabilization of specific chloroplast transcripts within the psbE and ndhH operons.","date":"2020","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/32343843","citation_count":25,"is_preprint":false},{"pmid":"11912165","id":"PMC_11912165","title":"VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.","date":"2002","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11912165","citation_count":25,"is_preprint":false},{"pmid":"30460984","id":"PMC_30460984","title":"Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.","date":"2019","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30460984","citation_count":24,"is_preprint":false},{"pmid":"21814157","id":"PMC_21814157","title":"IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis.","date":"2011","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/21814157","citation_count":24,"is_preprint":false},{"pmid":"17069926","id":"PMC_17069926","title":"The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2.","date":"2006","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/17069926","citation_count":24,"is_preprint":false},{"pmid":"9466931","id":"PMC_9466931","title":"Cross-talking among Drosophila nuclear receptors at the promiscuous response element of the ng-1 and ng-2 intermolt genes.","date":"1998","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9466931","citation_count":23,"is_preprint":false},{"pmid":"30250404","id":"PMC_30250404","title":"The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis.","date":"2018","source":"Journal of inflammation (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30250404","citation_count":22,"is_preprint":false},{"pmid":"31114590","id":"PMC_31114590","title":"Blocking IL-19 Signaling Ameliorates Allergen-Induced Airway Inflammation.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31114590","citation_count":21,"is_preprint":false},{"pmid":"30888496","id":"PMC_30888496","title":"Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp.","date":"2019","source":"European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/30888496","citation_count":21,"is_preprint":false},{"pmid":"32306980","id":"PMC_32306980","title":"Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24.","date":"2020","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32306980","citation_count":20,"is_preprint":false},{"pmid":"31379870","id":"PMC_31379870","title":"IL-19 Up-Regulates Mucin 5AC Production in Patients With Chronic Rhinosinusitis via STAT3 Pathway.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31379870","citation_count":19,"is_preprint":false},{"pmid":"16854693","id":"PMC_16854693","title":"Human fetal membrane expression of IL-19 and IL-20 and its differential effect on inflammatory cytokine production.","date":"2006","source":"The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","url":"https://pubmed.ncbi.nlm.nih.gov/16854693","citation_count":19,"is_preprint":false},{"pmid":"34600839","id":"PMC_34600839","title":"The role and transformative potential of IL-19 in atherosclerosis.","date":"2021","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/34600839","citation_count":18,"is_preprint":false},{"pmid":"34944021","id":"PMC_34944021","title":"IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34944021","citation_count":18,"is_preprint":false},{"pmid":"30761764","id":"PMC_30761764","title":"Expression of interleukin (IL)-10 family cytokines in aqueous humour of patients with specific endogenous uveitic entities: elevated levels of IL-19 in human leucocyte antigen-B27-associated uveitis.","date":"2019","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/30761764","citation_count":18,"is_preprint":false},{"pmid":"29500933","id":"PMC_29500933","title":"Treatment with IL-19 improves locomotor functional recovery after contusion trauma to the spinal cord.","date":"2018","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29500933","citation_count":15,"is_preprint":false},{"pmid":"33900049","id":"PMC_33900049","title":"IL-19 induced by IL-13/IL-17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP-9 expression via ERK/NF-κB signaling pathway.","date":"2021","source":"Clinical and translational allergy","url":"https://pubmed.ncbi.nlm.nih.gov/33900049","citation_count":15,"is_preprint":false},{"pmid":"20699607","id":"PMC_20699607","title":"Association analysis of genes of the IL19 cluster and their receptors in vitiligo patients.","date":"2010","source":"Dermatology (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/20699607","citation_count":14,"is_preprint":false},{"pmid":"25936211","id":"PMC_25936211","title":"Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19.","date":"2014","source":"Theoretical biology forum","url":"https://pubmed.ncbi.nlm.nih.gov/25936211","citation_count":13,"is_preprint":false},{"pmid":"30809889","id":"PMC_30809889","title":"MDA1, a nucleus-encoded factor involved in the stabilization and processing of the atpA transcript in the chloroplast of Chlamydomonas.","date":"2019","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30809889","citation_count":12,"is_preprint":false},{"pmid":"31539104","id":"PMC_31539104","title":"Exogenous IL-19 mediates downregulation of TGF-β through Erk and p38 pathway to inhibit epidural fibrosis.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31539104","citation_count":11,"is_preprint":false},{"pmid":"31386862","id":"PMC_31386862","title":"CD4 recovery is associated with genetic variation in IFNγ and IL19 genes.","date":"2019","source":"Antiviral research","url":"https://pubmed.ncbi.nlm.nih.gov/31386862","citation_count":10,"is_preprint":false},{"pmid":"34932373","id":"PMC_34932373","title":"Induction of IL19 expression through JNK and cGAS-STING modulates DNA damage-induced cytokine production.","date":"2021","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34932373","citation_count":10,"is_preprint":false},{"pmid":"35479078","id":"PMC_35479078","title":"Elevated IL-19 Serum Levels in Patients With Pernicious Anemia and Autoimmune Gastritis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35479078","citation_count":9,"is_preprint":false},{"pmid":"40057744","id":"PMC_40057744","title":"IL-19 as a promising theranostic target to reprogram the glioblastoma immunosuppressive microenvironment.","date":"2025","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/40057744","citation_count":9,"is_preprint":false},{"pmid":"25759841","id":"PMC_25759841","title":"Cloning of interleukin-10 from African clawed frog (Xenopus tropicalis), with the Finding of IL-19/20 homologue in the IL-10 locus.","date":"2015","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/25759841","citation_count":8,"is_preprint":false},{"pmid":"35369616","id":"PMC_35369616","title":"Combination of FLG mutations and SNPs of IL-17A and IL-19 influence on atopic dermatitis occurrence.","date":"2021","source":"Postepy dermatologii i alergologii","url":"https://pubmed.ncbi.nlm.nih.gov/35369616","citation_count":7,"is_preprint":false},{"pmid":"32561912","id":"PMC_32561912","title":"IL-10 and Its Related Superfamily Members IL-19 and IL-24 Provide Parallel/Redundant Immune-Modulation in Loa loa Infection.","date":"2021","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/32561912","citation_count":7,"is_preprint":false},{"pmid":"35928364","id":"PMC_35928364","title":"Comparison of TNF-α and IL-19 concentrations at different stages of breast cancer.","date":"2022","source":"Journal of medicine and life","url":"https://pubmed.ncbi.nlm.nih.gov/35928364","citation_count":6,"is_preprint":false},{"pmid":"37563485","id":"PMC_37563485","title":"Manipulation of osteogenic and adipogenic differentiation of human degenerative disc and ligamentum flavum derived progenitor cells using IL-1β, IL-19, and IL-20.","date":"2023","source":"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society","url":"https://pubmed.ncbi.nlm.nih.gov/37563485","citation_count":5,"is_preprint":false},{"pmid":"34044633","id":"PMC_34044633","title":"Association of BCL2 polymorphisms and the IL19 single nucleotide polymorphism rs2243188 with systemic lupus erythematosus.","date":"2021","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/34044633","citation_count":3,"is_preprint":false},{"pmid":"32111500","id":"PMC_32111500","title":"IL-19 as a Biomarker for the Severity of Acute Myocardial Infarction.","date":"2020","source":"Archives of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/32111500","citation_count":3,"is_preprint":false},{"pmid":"11055798","id":"PMC_11055798","title":"Intratumoral IL-12 gene transfer improves the therapeutic efficacy of IL-12 but not IL-19.","date":"2000","source":"Folia biologica","url":"https://pubmed.ncbi.nlm.nih.gov/11055798","citation_count":3,"is_preprint":false},{"pmid":"25633979","id":"PMC_25633979","title":"Immunogenetic influences on acquisition of HIV-1 infection: consensus findings from two African cohorts point to an enhancer element in IL19 (1q32.2).","date":"2015","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25633979","citation_count":2,"is_preprint":false},{"pmid":"23000500","id":"PMC_23000500","title":"IL-19 and IL-20 genes polymorphisms and haplotype analysis in a vesicoureteral reflux population.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23000500","citation_count":2,"is_preprint":false},{"pmid":"11118881","id":"PMC_11118881","title":"Functional analysis of regulatory elements controlling the expression of the ecdysone-regulated Drosophila ng-1 gene.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11118881","citation_count":2,"is_preprint":false},{"pmid":"40371466","id":"PMC_40371466","title":"IL-19 Is a Novel Lymphangiocrine Factor Inducing Lymphangiogenesis and Lymphatic Junctional Regulation.","date":"2025","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40371466","citation_count":1,"is_preprint":false},{"pmid":"40372535","id":"PMC_40372535","title":"Role of serum interleukin-19 (IL-19) levels in acne vulgaris: a comprehensive case control study.","date":"2025","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/40372535","citation_count":1,"is_preprint":false},{"pmid":"40647365","id":"PMC_40647365","title":"TOPK Drives IL19-Mediated Crosstalk Between Cancer Cells and Fibroblasts to Promote Solar UV-Induced Skin Damage and Carcinogenesis.","date":"2025","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/40647365","citation_count":1,"is_preprint":false},{"pmid":"40185911","id":"PMC_40185911","title":"The signature based on interleukin family and receptors identified IL19 and IL20RA in promoting nephroblastoma progression through STAT3 pathway.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40185911","citation_count":1,"is_preprint":false},{"pmid":"41103413","id":"PMC_41103413","title":"IL-19 suppresses Hippo signaling via modulating YAP1 phosphorylation in osteoarthritis.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41103413","citation_count":1,"is_preprint":false},{"pmid":"39007024","id":"PMC_39007024","title":"Immunohistochemical Analysis of IL-19 and IL-24 Expression in Inflammatory Bowel Disease (IBD) Patients: Results From a Single Center Retrospective Study.","date":"2024","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/39007024","citation_count":1,"is_preprint":false},{"pmid":"27974122","id":"PMC_27974122","title":"[Association between IL-19 gene polymorphisms and hepatitis B virus susceptibility in children].","date":"2016","source":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27974122","citation_count":1,"is_preprint":false},{"pmid":"34470933","id":"PMC_34470933","title":"[Therapeutic application utilizing the anti-inflammatory effect of IL-19].","date":"2021","source":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","url":"https://pubmed.ncbi.nlm.nih.gov/34470933","citation_count":0,"is_preprint":false},{"pmid":"38057085","id":"PMC_38057085","title":"Functional role of IL-19 in a mouse model of L-arginine-induced pancreatitis and related lung injury.","date":"2023","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/38057085","citation_count":0,"is_preprint":false},{"pmid":"41831327","id":"PMC_41831327","title":"Molecular characterization and functional analysis of IL-19 like in large yellow croaker (Larimichthys crocea).","date":"2026","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41831327","citation_count":0,"is_preprint":false},{"pmid":"41485927","id":"PMC_41485927","title":"[The significance of IL-19 in the liver: crosstalk among inflammation, metabolism, and fibrosis].","date":"2026","source":"Nihon yakurigaku zasshi. Folia pharmacologica Japonica","url":"https://pubmed.ncbi.nlm.nih.gov/41485927","citation_count":0,"is_preprint":false},{"pmid":"26522365","id":"PMC_26522365","title":"[Increased IL-19 level in peripheral blood of patients with allergic rhinitis is related with clinical severity].","date":"2015","source":"Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26522365","citation_count":0,"is_preprint":false},{"pmid":"41465543","id":"PMC_41465543","title":"Assessment of Serum and Saliva CRP, IL-17, and IL-19 Levels in Patients with Different Severity of Acne Vulgaris.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41465543","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.25.640192","title":"Distinct roles for thymic stromal lymphopoietin (TSLP) and IL-33 in experimental eosinophilic esophagitis","date":"2025-03-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.25.640192","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50166,"output_tokens":6427,"usd":0.123452},"stage2":{"model":"claude-opus-4-6","input_tokens":10150,"output_tokens":4218,"usd":0.2343},"total_usd":0.357752,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"IL-19 binds exclusively to the type I IL-20R complex (IL-20Rα/IL-20Rβ), not the type II complex (IL-22R/IL-20Rβ), and binding results in STAT3 phosphorylation and activation of STAT-responsive promoters.\",\n      \"method\": \"Receptor binding assays, STAT phosphorylation assays, reporter gene (minimal STAT-binding promoter) in cell lines\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct receptor binding and STAT3 phosphorylation demonstrated; replicated across two receptor complexes with clear specificity\",\n      \"pmids\": [\"11564763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"IL-19 mRNA is induced in monocytes by LPS stimulation (delayed relative to IL-10, detectable at 4 h); IL-19 does not signal through the canonical IL-10 receptor complex, implying a distinct receptor.\",\n      \"method\": \"Northern blot / RT-PCR time-course in LPS-stimulated monocytes; receptor binding exclusion experiments\",\n      \"journal\": \"Genes and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD/expression with defined cellular readout; single lab but multiple conditions\",\n      \"pmids\": [\"11196675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IL-19 treatment of monocytes induces production of IL-6 and TNF-α, promotes monocyte apoptosis, and increases reactive oxygen species production; IL-19 promoter region (394 bp upstream of exon 1) drives transcription.\",\n      \"method\": \"ELISA for cytokine production, apoptosis assays, luciferase reporter assay with promoter deletion constructs\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ELISA, apoptosis, ROS, reporter); single lab\",\n      \"pmids\": [\"12370360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"IL-19 induces Th2 cytokine production (IL-4, IL-5, IL-10, IL-13) in activated T cells; induction of IL-13 requires prior T cell activation.\",\n      \"method\": \"In vitro cytokine stimulation of T cells, ELISA for cytokine production; in vivo gene electroporation in mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo data with defined cytokine readouts; single lab\",\n      \"pmids\": [\"15557163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"IL-19 stimulates its own expression (auto-induction) and induces IL-10 production in PBMCs; IL-10 in turn potently down-regulates IL-19 auto-induction; IL-19 acts as a transcriptional activator of IL-10 (increased IL-10 mRNA); IL-19 skews dendritic cell maturation toward increased IL-10 without affecting IL-12.\",\n      \"method\": \"Quantitative RT-PCR, ELISA on PBMC supernatants, dendritic cell differentiation assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RT-PCR, ELISA, DC assay); single lab\",\n      \"pmids\": [\"15827959\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"IL-19 (along with IL-20 and IL-24) does not activate STAT molecules in immune cells (consistent with absence of cognate receptor chains IL-20R1/IL-20R2 on immune cells); instead, acts on skin keratinocytes and other epithelial tissues expressing both receptor complexes.\",\n      \"method\": \"STAT phosphorylation assays in immune and epithelial cells; RT-PCR and flow cytometry for receptor expression\",\n      \"journal\": \"Experimental dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic receptor expression and signaling analysis across cell types; single lab but multiple methods\",\n      \"pmids\": [\"17083366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A2B adenosine receptor activation on bronchial epithelial cells induces IL-19 release; released IL-19 activates monocytes to produce TNF-α, which in turn upregulates A2B receptor expression, forming a positive inflammatory feedback loop.\",\n      \"method\": \"NECA treatment + selective A2B antagonist CVT-6694 in HBEC cultures; ELISA for IL-19 and TNF-α; THP-1 monocyte activation assays\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological receptor blockade plus functional cytokine readouts; single lab\",\n      \"pmids\": [\"16778150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IL-19 induces STAT3 activation and increases IL-6 production in rheumatoid arthritis synovial cells (RASC); IL-19 reduces RASC apoptosis induced by serum starvation, suggesting an anti-apoptotic autocrine role in synovial hyperplasia.\",\n      \"method\": \"Western blot for STAT3 phosphorylation, ELISA for IL-6, Hoechst staining, annexin V flow cytometry, caspase-3 activity assay\",\n      \"journal\": \"Rheumatology (Oxford)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal apoptosis and signaling assays; single lab\",\n      \"pmids\": [\"18397956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IL-17A and IL-4/IL-13 synergistically upregulate IL-19 expression in airway epithelial cells; IL-19 transcription is regulated by NF-κB, and the IL-13+IL-17A combination shifts this to STAT6-dependent regulation; STAT6-binding elements were confirmed in the IL-19 promoter by chromatin immunoprecipitation.\",\n      \"method\": \"siRNA knockdown, chemical inhibitors, chromatin immunoprecipitation (ChIP), luciferase reporter assays, well-differentiated primary bronchial epithelial cultures\",\n      \"journal\": \"Journal of allergy and clinical immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP + siRNA + inhibitor approaches provide strong mechanistic evidence for transcriptional regulation\",\n      \"pmids\": [\"18539194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"IL-19 reduces abundance and stability of proliferative/inflammatory mRNAs (Cyclin D1, IL-1β, IL-8, COX2) in vascular smooth muscle cells (VSMC) by decreasing cytoplasmic abundance and serine phosphorylation of the mRNA stability factor HuR, and by reducing PKCα activation; actinomycin D chase confirms reduced mRNA half-life; HuR siRNA knockdown phenocopies IL-19.\",\n      \"method\": \"Actinomycin D transcription block mRNA decay assays, immunoblot for HuR and PKCα, HuR siRNA knockdown, quantitative RT-PCR\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (mRNA decay, siRNA, kinase phosphorylation) in primary human VSMCs; single lab but rigorous\",\n      \"pmids\": [\"20451530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"IL-19 induces HO-1 mRNA and protein expression in human VSMC (not endothelial cells) via STAT3 activation; STAT3 siRNA and mutation of the STAT-binding site in the HO-1 promoter significantly reduce IL-19-induced HO-1; IL-19-driven HO-1 mediates reduction of ROS concentrations; IL-19 reduces vascular ROS in vivo in TNFα-treated mice.\",\n      \"method\": \"Quantitative RT-PCR, immunoblot, ELISA, STAT3 siRNA, HO-1 promoter mutagenesis, annexin V flow cytometry, in vivo ROS measurement\",\n      \"journal\": \"Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — promoter mutagenesis + siRNA + in vitro and in vivo ROS assays; multiple orthogonal methods\",\n      \"pmids\": [\"22158875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IL-19 promotes cutaneous wound healing in vivo; in vitro, IL-19 upregulates KGF (keratinocyte growth factor) expression in fibroblasts, and conditioned medium from IL-19-treated fibroblasts promotes keratinocyte proliferation; IL-19 directly increases keratinocyte migration.\",\n      \"method\": \"Full-thickness mouse wound model with topical IL-19; BrdU proliferation assay, transwell migration assay, RT-PCR, conditioned medium transfer\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro functional assays with defined cellular mechanisms; single lab\",\n      \"pmids\": [\"23582717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IL-19 knockout mice develop more severe neointimal hyperplasia after carotid artery ligation; IL-19 KO VSMCs proliferate and migrate faster, with greater inflammatory cytokine expression and monocyte adhesion; all phenotypes are rescued by exogenous recombinant IL-19.\",\n      \"method\": \"IL-19 knockout mouse carotid ligation model, neointima/intima ratio morphometry, VSMC proliferation/migration assays, recombinant IL-19 rescue injection\",\n      \"journal\": \"American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with rescue by exogenous protein, multiple in vitro and in vivo phenotypic readouts; replicated across multiple assays\",\n      \"pmids\": [\"24814101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IL-19 production is induced in keratinocytes by IL-17A and amplified by TNF-α and IL-22; IL-19 amplifies IL-17A effects on keratinocytes including induction of β-defensins, IL-19 itself, IL-23p19, and Th17/neutrophil-attracting chemokines; IL-19 is a component of the IL-23/IL-17 pathogenic axis in psoriasis.\",\n      \"method\": \"Primary keratinocyte stimulation, quantitative cytokine measurement, gene expression analysis\",\n      \"journal\": \"Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic functional studies in primary keratinocytes with defined cytokine stimuli and readouts; single lab\",\n      \"pmids\": [\"25046339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Exogenous IL-19 halts progression of preformed atherosclerotic plaque in LDLR−/− mice; IL-19 promotes M2 macrophage polarization via activation of STAT3, STAT6, KLF4, and PPARγ; IL-19 regulates macrophage cholesterol homeostasis through PPARγ-dependent scavenger receptor-mediated cholesterol uptake and ABCA1-mediated cholesterol efflux.\",\n      \"method\": \"LDLR−/− mouse atherosclerosis model with rIL-19 injection, plaque morphometry, immunostaining, western blot for STAT3/STAT6/KLF4/PPARγ pathway components, cholesterol uptake and efflux assays\",\n      \"journal\": \"American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model with mechanistic pathway validation using multiple signaling and lipid metabolism assays; rigorous\",\n      \"pmids\": [\"26952642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"IL-19 induces expression of miR133a in VSMC; miR133a targets and reduces mRNA abundance, stability, and protein expression of LDLRAP1 (LDL receptor adaptor protein 1), thereby reducing oxLDL uptake and lipid accumulation in VSMCs.\",\n      \"method\": \"miRNA quantification, miR133a transfection, LDLRAP1 siRNA, mRNA stability assays, oxLDL uptake assays in primary human VSMCs; miR133a plasma measurement in hyperlipidemic patients\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA and miRNA overexpression with mRNA stability and functional lipid uptake assays; single lab\",\n      \"pmids\": [\"28257760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-19 genetic deletion (Il19−/− × Ldlr−/− double KO) exacerbates atherosclerosis; dKO mice show increased HuR (mRNA stability protein) abundance in spleen and aortic arch; IL-19 induces miR133a which targets and reduces HuR; loss of IL-19 increases inflammatory cytokine mRNA stability via elevated HuR.\",\n      \"method\": \"Double KO mouse model, bone marrow transplantation, qRT-PCR, western blot, mRNA stability assays in isolated BMDM and VSMCs, miR133a quantification\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO model with bone marrow transplantation to define cellular source, multiple orthogonal molecular assays; strong evidence\",\n      \"pmids\": [\"29674474\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FXR1 (fragile-X-related protein) is identified as an IL-19-responsive, HuR-interacting protein in VSMCs; FXR1-HuR interaction is RNA-tethered (abrogated by RNase); FXR1 destabilizes pro-inflammatory mRNAs (including TNFα, which it binds via ARE and 3' UTR elements); IL-19 increases FXR1 expression and FXR1 is required for IL-19-mediated reduction of HuR.\",\n      \"method\": \"LC-MS/MS proteomics, RNA EMSA, RNA immunoprecipitation (RIP), siRNA knockdown, FXR1 overexpression, mRNA stability assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — proteomics identification with RNA EMSA, RIP, siRNA rescue, and mRNA stability; multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"30067974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IL-20R1 deficiency abolishes IL-19-induced Th2 cell differentiation in vitro; in vivo, IL-20R1 deficiency reduces allergen-induced airway hyperresponsiveness, Th2 cytokine expression, and immune cell infiltration; anti-IL-20R1 mAb and anti-IL-19 antibodies both ameliorate allergic lung inflammation.\",\n      \"method\": \"IL-20R1 KO mouse model, anti-IL-20R1 mAb treatment, anti-IL-19 pAb, in vitro Th2 differentiation assay, airway hyperresponsiveness measurement, BAL cell counting\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with pharmacological rescue, multiple in vivo and in vitro readouts; mechanistically defines IL-20R1 as the required signaling receptor for IL-19-driven Th2 responses\",\n      \"pmids\": [\"31114590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IL-19 up-regulates MUC5AC mucin production in primary human nasal epithelial cells via STAT3 pathway; IL-20R2 siRNA knockdown and STAT3 inhibitor (cryptotanshinone) attenuate IL-19-induced MUC5AC.\",\n      \"method\": \"Recombinant IL-19 stimulation of primary nasal epithelial cells, siRNA knockdown of IL-20R2, STAT3 inhibitor, RT-qPCR, ELISA, western blot, confocal microscopy\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA and pharmacological inhibitor approaches with multiple readouts; single lab\",\n      \"pmids\": [\"31379870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-19 is produced predominantly by osteocytes and stimulates granulopoiesis by activating IL-20Rβ/STAT3 signaling in neutrophil progenitors; mTORC1 activation in osteocytes increases IL-19 production and promyelocyte expansion; neutralizing endogenous IL-19 or depleting its receptor inhibits neutrophil development; low-dose IL-19 reverses chemotherapy/irradiation-induced neutropenia.\",\n      \"method\": \"Dmp1-Cre mTORC1 activation mouse model, IL-19 neutralizing antibody, IL-20Rβ depletion, bone marrow analysis, STAT3 activation assays, neutropenia rescue experiments\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic mouse models, receptor depletion, neutralization, and in vivo rescue; multiple orthogonal approaches establishing pathway position\",\n      \"pmids\": [\"33684929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DNA damage induces IL-19 expression through JNK and cGAS-STING pathways; IL-19 expression is required for subsequent DNA damage-induced production of IL-1, IL-6, and IL-8; IL-19 induction by ionizing radiation depends on reactive oxygen species and ASK1-JNK, while ATR inhibition-induced IL-19 requires cGAS-STING; IL-19-independent cGAS-STING signaling drives PDL1 expression.\",\n      \"method\": \"Pathway inhibitors (JNK, ROS, cGAS-STING), siRNA suppression of IL19, ATR inhibitor treatment, ionizing radiation, cytokine ELISA, gene expression analysis\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown of IL19 combined with multiple genetic/pharmacological pathway interrogations; epistasis established between DNA damage pathways and IL-19-dependent cytokine cascade\",\n      \"pmids\": [\"34932373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-17A induces IL-19 and IL-24 expression directly in skin fibroblasts and keratinocytes; intrinsic higher IL-19 expression in psoriatic versus healthy skin fibroblasts; IL-17A neutralization in T cell-fibroblast co-culture suppresses IL-19 and IL-24; IL-19 (with IL-24) contributes to keratinocyte proliferation.\",\n      \"method\": \"Human skin fibroblast-T cell co-culture, anti-IL-17A neutralization, imiquimod mouse psoriasis model with anti-IL-10 antibody, histology, flow cytometry\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — neutralization in co-culture plus in vivo mouse model; single lab\",\n      \"pmids\": [\"34616394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IL-19 KO mice on CDAHFD develop worse NASH (more liver injury, inflammation, fibrosis, elevated IL-6/TNF-α/TGF-β); in vitro, IL-19 decreases palmitate-induced triglyceride and cholesterol accumulation in hepatocytes, reduces fatty acid synthesis gene expression, and increases ATP content, indicating IL-19 suppresses lipid metabolism in hepatocytes.\",\n      \"method\": \"IL-19 KO mouse CDAHFD model, histopathology, qRT-PCR, ELISA, in vitro HepG2 lipid accumulation assays\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse phenotype with in vitro mechanistic follow-up; single lab\",\n      \"pmids\": [\"34944021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"IL-19 promotes lymphangiogenesis (human dermal lymphatic endothelial cell migration, network formation, proliferation); IL-19 induces rapid VE-cadherin phosphorylation and increases lymphatic endothelial monolayer permeability; Il19/Ldlr double KO mice on high-fat diet show impaired lymphatic drainage, fewer lymphatic branch points, and increased zipper junctions.\",\n      \"method\": \"Human dermal lymphatic endothelial cell culture assays, immunocytochemistry, electric cell-substrate impedance sensing, RNA sequencing, in vivo lymphatic drainage in double KO mice\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assays with in vivo genetic model validation; single lab\",\n      \"pmids\": [\"40371466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"IL-19 induces MMP-9 production in human nasal epithelial cells through ERK and NF-κB signaling pathways; ERK and NF-κB inhibitors attenuate IL-19-induced MMP-9; siRNA knockdown of IL-20R1 suppresses ERK/NF-κB activation and MMP-9 expression; IL-13 and IL-17A stimulate IL-19 production in nasal epithelial cells.\",\n      \"method\": \"siRNA knockdown of IL-20R1, ERK and NF-κB inhibitors, western blot, RT-qPCR, ELISA, immunofluorescence in primary human nasal epithelial cells\",\n      \"journal\": \"Clinical and translational allergy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA and pharmacological inhibition with multiple readouts; single lab\",\n      \"pmids\": [\"33900049\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"IL-19 is an IL-10 family cytokine that signals exclusively through the type I IL-20R complex (IL-20Rα/IL-20Rβ) to activate STAT3, driving diverse context-dependent anti- or pro-inflammatory effects: in vascular smooth muscle cells it suppresses inflammatory mRNA stability by reducing HuR via miR133a induction and increasing the counter-regulatory RNA-binding protein FXR1; in immune and epithelial cells it promotes Th2 polarization and keratinocyte responses; it is induced by DNA damage via JNK and cGAS-STING pathways and is required upstream of IL-1/IL-6/IL-8 production; and in osteocytes it drives neutrophil progenitor expansion through IL-20Rβ/STAT3 signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"IL-19 is an IL-10 family cytokine that orchestrates context-dependent inflammatory, vascular, and tissue-repair responses by signaling through the IL-20Rα/IL-20Rβ (type I IL-20R) complex to activate STAT3, and in specific contexts STAT6, ERK, and NF-κB [PMID:11564763, PMID:22158875, PMID:31379870, PMID:33900049]. In vascular smooth muscle cells, IL-19 suppresses inflammatory mRNA stability by inducing miR133a, which reduces the mRNA-stabilizing factor HuR, and by upregulating the counter-regulatory RNA-binding protein FXR1, collectively destabilizing transcripts encoding cyclin D1, IL-1β, IL-8, and TNFα [PMID:20451530, PMID:30067974, PMID:29674474]. In immune cells, IL-19 promotes Th2 polarization and IL-10 induction through IL-20R1-dependent signaling, drives M2 macrophage polarization via STAT3/KLF4/PPARγ to limit atherosclerosis, and stimulates granulopoiesis through IL-20Rβ/STAT3 in neutrophil progenitors, while in epithelial and endothelial cells it induces mucin (MUC5AC), MMP-9, keratinocyte proliferation, and lymphangiogenesis [PMID:31114590, PMID:26952642, PMID:33684929, PMID:31379870, PMID:40371466]. IL-19 expression is transcriptionally regulated by NF-κB and STAT6 in response to IL-17A, IL-13, and LPS, and is induced by DNA damage through JNK and cGAS-STING pathways, positioning it as a required upstream mediator of damage-induced IL-1/IL-6/IL-8 production [PMID:18539194, PMID:34932373].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that IL-19 is an inducible monocyte cytokine distinct from IL-10 answered whether IL-19 uses the IL-10 receptor, demonstrating it signals through an independent pathway.\",\n      \"evidence\": \"Northern blot/RT-PCR time-course in LPS-stimulated monocytes with receptor binding exclusion\",\n      \"pmids\": [\"11196675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cognate receptor not yet identified\", \"Downstream signaling pathway unknown\", \"Single-lab observation\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of IL-20Rα/IL-20Rβ as the exclusive receptor complex and STAT3 as the principal effector resolved how IL-19 transduces signal, establishing its mechanistic distinction from other IL-10 family members.\",\n      \"evidence\": \"Receptor binding assays and STAT3 phosphorylation/reporter assays across both IL-20R complexes\",\n      \"pmids\": [\"11564763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets of STAT3 in this context undefined\", \"Cell-type specificity of receptor expression not systematically mapped\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that IL-19 induces IL-6, TNFα, apoptosis, and ROS in monocytes established it as a pro-inflammatory stimulus in myeloid cells, posing the question of how this reconciles with its IL-10-family membership.\",\n      \"evidence\": \"ELISA, apoptosis assays, ROS measurement, and promoter-reporter analysis in monocytes\",\n      \"pmids\": [\"12370360\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor expression on monocytes not directly confirmed\", \"Whether effects are direct or paracrine not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showing IL-19 drives Th2 cytokine production (IL-4, IL-5, IL-10, IL-13) in T cells established its role as a Th2-polarizing cytokine, later confirmed genetically.\",\n      \"evidence\": \"In vitro T cell cytokine stimulation and in vivo gene electroporation in mice\",\n      \"pmids\": [\"15557163\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether IL-19 acts directly on T cells or through APCs not resolved\", \"Receptor expression on T cells not confirmed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Discovery of IL-19 auto-induction and reciprocal IL-10 feedback defined a self-amplifying circuit with a built-in brake, explaining how IL-19 responses are calibrated.\",\n      \"evidence\": \"qRT-PCR and ELISA in PBMCs; dendritic cell maturation assays\",\n      \"pmids\": [\"15827959\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of auto-induction not defined\", \"In vivo relevance of feedback loop not tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Systematic analysis showing IL-19 activates STAT in epithelial/keratinocyte cells but not immune cells clarified cell-type-restricted signaling, and the A2B adenosine receptor–IL-19–TNFα loop placed IL-19 in airway inflammatory amplification circuits.\",\n      \"evidence\": \"STAT phosphorylation across cell types; A2B receptor pharmacological blockade with cytokine ELISA\",\n      \"pmids\": [\"17083366\", \"16778150\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Apparent contradiction with monocyte activation data from 2002 not reconciled\", \"Whether receptor expression is regulated dynamically under inflammation not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two advances established transcriptional regulation of IL-19 (NF-κB and STAT6 via IL-17A/IL-13 in airway epithelia) and its autocrine role in synovial cells (STAT3 → IL-6, anti-apoptosis), connecting IL-19 to both upstream inducers and downstream effector pathways in disease-relevant tissues.\",\n      \"evidence\": \"ChIP, siRNA, inhibitor, and promoter mutagenesis in bronchial epithelial cells; STAT3/apoptosis assays in rheumatoid synovial cells\",\n      \"pmids\": [\"18539194\", \"18397956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether STAT6 regulation applies beyond airway epithelium unknown\", \"In vivo evidence for synovial autocrine loop lacking\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identification of HuR destabilization as the mechanism by which IL-19 reduces inflammatory mRNA half-life in VSMCs established a post-transcriptional anti-inflammatory mechanism distinct from transcriptional repression.\",\n      \"evidence\": \"Actinomycin D mRNA decay assays, HuR immunoblot, PKCα analysis, HuR siRNA phenocopy in primary human VSMCs\",\n      \"pmids\": [\"20451530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal from IL-20R/STAT3 to PKCα/HuR not delineated\", \"Whether mechanism operates in non-vascular cell types unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing IL-19 induces HO-1 via STAT3 to reduce ROS in VSMCs and in vivo established a cytoprotective effector arm, broadening IL-19's anti-inflammatory repertoire beyond mRNA destabilization.\",\n      \"evidence\": \"STAT3 siRNA, HO-1 promoter mutagenesis, in vivo ROS measurement in TNFα-treated mice\",\n      \"pmids\": [\"22158875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of HO-1 versus HuR pathway not assessed\", \"Whether HO-1 induction occurs in macrophages unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"IL-19 KO mice developing worse neointimal hyperplasia provided genetic loss-of-function evidence that endogenous IL-19 is a vascular-protective factor, while keratinocyte studies placed IL-19 within the IL-23/IL-17 psoriatic axis as an amplifier.\",\n      \"evidence\": \"IL-19 KO carotid ligation model with rescue; primary keratinocyte cytokine stimulation\",\n      \"pmids\": [\"24814101\", \"25046339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific conditional KO not performed\", \"Whether vascular protection is VSMC-autonomous or involves macrophage M2 polarization unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstration that exogenous IL-19 halts atherosclerotic plaque progression via M2 macrophage polarization (STAT3/STAT6/KLF4/PPARγ) and cholesterol efflux established a multi-pronged atheroprotective mechanism acting on both inflammation and lipid handling.\",\n      \"evidence\": \"LDLR−/− mouse atherosclerosis model with rIL-19 injection; cholesterol uptake/efflux assays; signaling pathway western blots\",\n      \"pmids\": [\"26952642\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous IL-19 levels are sufficient for this effect not tested at this point\", \"STAT6 activation had not been previously reported for IL-19 — mechanism of STAT6 engagement not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of miR133a as the mediator by which IL-19 reduces HuR and LDLRAP1 connected IL-19 signaling to a specific microRNA effector and explained how IL-19 limits oxLDL uptake in VSMCs.\",\n      \"evidence\": \"miR133a quantification, transfection, LDLRAP1 siRNA, mRNA stability and oxLDL uptake assays in primary human VSMCs\",\n      \"pmids\": [\"28257760\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Transcriptional mechanism by which IL-19/STAT3 induces miR133a not defined\", \"Single-lab finding without independent replication\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Double-KO (Il19/Ldlr) mice confirmed IL-19 genetically restrains atherosclerosis through miR133a-HuR-dependent inflammatory mRNA destabilization, while parallel work identified FXR1 as a novel IL-19-induced RNA-binding protein that antagonizes HuR and is required for IL-19's post-transcriptional anti-inflammatory activity.\",\n      \"evidence\": \"Double KO mouse with bone marrow transplantation, miR133a and HuR quantification; LC-MS/MS proteomics, RNA EMSA, RIP, siRNA in VSMCs\",\n      \"pmids\": [\"29674474\", \"30067974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FXR1 functions downstream of miR133a or in parallel not determined\", \"FXR1-HuR interaction characterized only in VSMCs\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic and antibody-mediated disruption of IL-20R1 abolished IL-19-driven Th2 differentiation and allergic airway inflammation in vivo, definitively establishing the receptor requirement for IL-19's immune-polarizing function; concurrent studies showed IL-19 also engages ERK/NF-κB through IL-20R1 to induce MMP-9 in nasal epithelia.\",\n      \"evidence\": \"IL-20R1 KO mice, anti-IL-20R1 mAb, anti-IL-19 pAb in allergic airway model; siRNA and pharmacological inhibition in nasal epithelial cells\",\n      \"pmids\": [\"31114590\", \"33900049\", \"31379870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How STAT3 versus ERK/NF-κB pathway selection occurs in different cell types undefined\", \"Whether IL-20R1 blockade is therapeutic in human asthma not tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Three distinct advances established IL-19 as: (1) the critical osteocyte-derived cytokine driving granulopoiesis via IL-20Rβ/STAT3 in neutrophil progenitors, rescuing chemotherapy-induced neutropenia; (2) a required intermediary in DNA damage-induced cytokine cascades through JNK and cGAS-STING; and (3) a hepatoprotective factor suppressing NASH-associated lipid accumulation.\",\n      \"evidence\": \"Dmp1-Cre mTORC1 mouse model with IL-19 neutralization and neutropenia rescue; siRNA/inhibitor epistasis after irradiation and ATR inhibition; IL-19 KO NASH model with in vitro hepatocyte lipid assays\",\n      \"pmids\": [\"33684929\", \"34932373\", \"34944021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether osteocyte-derived IL-19 contributes to steady-state versus emergency granulopoiesis not fully resolved\", \"cGAS-STING-to-IL-19 transcriptional mechanism not defined\", \"NASH findings from single lab, not replicated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that IL-19 promotes lymphangiogenesis and regulates lymphatic endothelial permeability via VE-cadherin phosphorylation expanded its vascular biology to the lymphatic system, with Il19/Ldlr double KO mice showing impaired lymphatic drainage.\",\n      \"evidence\": \"Lymphatic endothelial cell migration/network/proliferation assays, impedance sensing, RNA-seq, in vivo lymphatic drainage in double KO mice\",\n      \"pmids\": [\"40371466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor and STAT pathway mediating lymphatic effects not defined\", \"Single-lab finding\", \"Whether lymphatic phenotype contributes to atherosclerosis severity not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis and selectivity determinants of IL-19 binding to IL-20Rα/IL-20Rβ; the mechanism by which STAT3 activation leads to miR133a induction; how cell-type-specific pathway selection (STAT3 vs. STAT6 vs. ERK/NF-κB) is determined; and whether the post-transcriptional FXR1/HuR axis operates beyond vascular smooth muscle cells.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure of IL-19–receptor complex\", \"miR133a transcriptional regulation by STAT3 not demonstrated directly\", \"FXR1 pathway not tested in macrophages, keratinocytes, or neutrophil progenitors\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 17, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 2, 3, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 7, 10, 14, 18, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 4, 13, 18]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [9, 15, 16, 17]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [8, 21]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [14, 23]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"IL20RA\",\n      \"IL20RB\",\n      \"STAT3\",\n      \"HuR\",\n      \"FXR1\",\n      \"PPARG\",\n      \"KLF4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}